← FDA DRUG APPROVALS

FDA ANDA · ANDA205348

MOXIFLOXACIN HYDROCHLORIDE

Sponsor: CROSSMEDIKA SA

APPLICATION
ANDA205348
TYPE
ANDA
ORIGINAL APPROVAL
2016-01-14
LATEST ACTION
2025-04-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

MOXIFLOXACIN HYDROCHLORIDEPrescription
MOXIFLOXACIN HYDROCHLORIDE EQ 400MG BASE · TABLET · ORAL

Approval history

2025-04-14Labeling · Supplement 6 · standardAP
2020-02-07Labeling · Supplement 1 · standardAP
2020-02-07Labeling · Supplement 4 · standardAP
2020-02-07Labeling · Supplement 2 · standardAP
2016-01-14UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →